This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Sanchez-Munoz A, Mendiola C, Perez-Ruiz E, Rodriguez-Sanchez CA, Jurado JM, Alonso-Carrion L, Ghanem I, De Velasco G, Quero-Blanco C, Alba E.Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer. Oncology 79: 98-104, No. 12, Dec 2010. Available from: URL: http://dx.doi.org/10.1159/000320602 - Spain
Rights and permissions
About this article
Cite this article
Bevacizumab/cyclophosphamide. React. Wkly. 1339, 11 (2011). https://doi.org/10.2165/00128415-201113390-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113390-00029